With a market cap of $29.2 billion, Veeva Systems Inc. (VEEV) is a leading provider of industry-specific cloud solutions for the life sciences sector, offering cloud software, AI, data, and business consulting services. As a Public Benefit Corporation, Veeva is committed to driving innovation, product excellence, and customer success while balancing the interests of its customers, employees, shareholders, and the industries it serves.
The Pleasanton, California-based company is slated to announce its fiscal Q2 2027 results soon. Ahead of the event, analysts expect VEEV to report an adjusted EPS of $1.62, up 28.6% from $1.26 in the year-ago quarter. It has surpassed Wall Street's bottom-line estimates in three of the past four quarterly reports while missing on another occasion.
More Top Stocks Daily: Go behind Wall Street’s hottest headlines with Barchart’s Active Investor newsletter.
For fiscal 2026, analysts predict Veeva Systems to post adjusted EPS of $6.65, a 13.5% increase from $5.86 in fiscal 2025.
www.barchart.com Shares of Veeva Systems have declined 36.8% over the past 52 weeks, lagging behind both the S&P 500 Index's ($SPX) 16.6% gain and the State Street Health Care Select Sector SPDR ETF's (XLV) 19.5% return over the same period.
www.barchart.com Veeva Systems reported fiscal Q1 2027 results on June 3 that exceeded its guidance, with total revenue increasing 16% year-over-year to $882.9 million, subscription revenue rising 15% to $730.2 million, and adjusted EPS improving to $2.24. The company also delivered strong profitability, with operating income up 17% to $273.1 million and net income up 14% to $260.9 million, while continuing to expand its AI-driven offerings, including Vault AI, Veeva Falcon, and Ostro.
Additionally, Veeva raised its fiscal 2027 guidance, forecasting $3.64 billion - $3.65 billion in revenue, approximately $1.61 billion in adjusted operating income, and around $9.05 in adjusted EPS. However, the stock fell marginally the next day.
Analysts' consensus rating on VEEV stock is cautiously optimistic, with an overall "Moderate Buy" rating. Among 27 analysts covering the stock, 15 recommend a "Strong Buy,” three have a "Moderate Buy" rating, eight give a "Hold" rating, and one has a "Strong Sell.” The average analyst price target is $238.52, indicating a potential upside of 29.6% from the current levels.
On the date of publication, Sohini Mondal did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here.
More news from Barchart
This Little-Known Biotech Stock Just Hit a New 5-Year High This Top Utility Stock Is Getting a Big Boost From Massive OpenAI Power Deal CBRS Stock Alert: What to Know as Cerebras Teams Up With AMD Dell Jumps 10% on AI Server Optimism. Here's What It Means for DELL Stock.